SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pseudo Biologist who wrote (41)9/5/1997 6:01:00 PM
From: biowa   of 3044
 
MPB,

Welcome back. I know all too well how the catch up game goes.

>>Lander and a few others mentioned today had been associated with MLNM all along, so what's the news here?<<

I think there's two pieces of news here:

MLNM is wrapping itself even tighter to Whitehead; a real positive, since I think the functional genomics collab w/ then, if successful can be a real asset.

At lot of the expertise seems to be post genomics; INCY can afford to emphasize genomics, since that's essentially what they get paid to do (ignoring the new direction in diaDexus), MLNM has always, and even more now, emphasized validating targets and even developing candidates.

But, all-in-all, this isn't earth-shattering. I expect more of that type of news in the 4Q.

biowa
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext